ArticleBMC pediatrics2025

Use of complement C5-inhibitor eculizumab in patients with infection-associated hemolytic uremic syndrome - a case-series report.

Petra Varga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.